Juvenile recurrent respiratory papillomatosis - Symptoms, Causes, Treatment & Prevention

Overview

Juvenile Recurrent Respiratory Papillomatosis (JRRP) is a rare, chronic disease in which benign (non‑cancerous) wart‑like growths (papillomas) develop on the airway, most often on the vocal cords and larynx. The papillomas can obstruct the airway, cause hoarseness, and, in severe cases, lead to life‑threatening breathing problems.

Although the name includes “juvenile,” the condition can persist into adulthood and may recur many times over a patient’s lifetime. JRRP is the most common cause of a benign airway tumor in children.

• Typical age of onset: 2–5 years (90 % of cases); rare cases are diagnosed in infants.
• Gender: Slight male predominance (≈ 55 % male).
• Prevalence: Estimated 1–4 cases per 100,000 children in the United States; worldwide incidence is similar, with higher rates reported in regions with limited vaccination against human papillomavirus (HPV) [1][2].

Symptoms

Symptoms reflect the location and size of papillomas. Because the growths are often multiple and may recur, the clinical picture can change over time.

Upper airway (larynx, trachea)

• Hoarseness or a “raspy” voice: The earliest and most common sign, present in > 80 % of children.
• Stridor: High‑pitched breathing sound, especially during inspiration; indicates airway narrowing.
• Breathlessness or wheezing: May be mistaken for asthma.
• Chronic cough: Often dry and non‑productive.
• Voice fatigue: Voice becomes weaker after talking.

Lower airway (trachea, bronchi)

• Persistent cough that worsens at night.
• Recurrent chest infections or pneumonia.
• Hemoptysis (coughing up blood) – rare but possible if papillomas ulcerate.

Systemic / related symptoms

• Feeding difficulty or choking in infants.
• Failure to thrive due to chronic respiratory effort.
• Sleep‑disordered breathing or apnea.

Causes and Risk Factors

JRRP is caused by infection with human papillomavirus (HPV) types 6 and 11, which are low‑risk strains that rarely cause cancer but can produce proliferative lesions in the respiratory tract.

Transmission pathways

• Vertical transmission: The mother passes HPV to the infant during passage through the birth canal. This is the most widely accepted route for JRRP.
• Perinatal exposure: Contact with infected genital secretions or contaminated instruments during delivery.
• Rare post‑natal transmission: Through close contact with an infected caregiver’s oral secretions (e.g., kissing, sharing utensils).

Risk factors

• Maternal infection with HPV 6 or 11 during pregnancy.
• Delivery by vaginal birth (vs. elective cesarean) – higher exposure to genital HPV.
• Maternal smoking or immunosuppression, which can increase viral load.
• Families with a history of recurrent respiratory papillomatosis (autosomal dominant rare familial forms reported).

Diagnosis

Diagnosis relies on a combination of clinical suspicion, visual examination, and laboratory confirmation.

1. Clinical evaluation

• Detailed history of voice changes, breathing difficulty, and maternal HPV status.
• Physical exam focusing on the neck, airway, and signs of respiratory distress.

2. Direct visualization

The gold‑standard test is **flexible or rigid laryngoscopy** performed by an otolaryngologist (ENT specialist). Papillomas appear as gelatinous, cauliflower‑like lesions on the vocal cords or tracheal walls.

3. Imaging (adjunct)

• Neck X‑ray or lateral soft‑tissue neck film: May show airway narrowing.
• CT scan of the neck/chest: Helpful for extensive disease or if papillomas extend into the bronchi.

4. Histopathology

Biopsy of a lesion confirms the diagnosis and helps rule out malignancy. Microscopic features include squamous epithelium with koilocytosis (HPV‑specific changes). Immunohistochemical staining for HPV capsid protein can be performed.

5. Molecular testing

Polymerase chain reaction (PCR) or in‑situ hybridization can detect HPV DNA, identifying type 6 or 11 in > 90 % of cases. This information guides therapeutic decisions (e.g., use of HPV‑targeted vaccines).

Treatment Options

There is currently no cure; treatment aims to control disease, maintain airway patency, and preserve voice quality. A multidisciplinary team (ENT surgeon, pulmonologist, speech therapist, and sometimes oncologist) is ideal.

1. Surgical removal

• Microlaryngoscopic debulking: The most common initial therapy; uses a microscope and micro‑instruments to excise papillomas.
• Laser ablation (CO₂ or KTP laser): Precise vaporization; reduces bleeding.
• Microdebrider: Rotating blade that shaves tissue; useful for larger lesions.
• Repeated procedures are often required; median interval between surgeries is 3–6 months.

2. Adjuvant medical therapies

• Intralesional cidofovir: Antiviral nucleoside analogue; shown to reduce recurrence in some studies (Level B evidence) [3].
• Interferon‑α: Immunomodulator; less commonly used due to flu‑like side effects.
• Systemic bevacizumab (anti‑VEGF): Emerging therapy for severe disease; early case series show decreased papilloma burden.
• HPV therapeutic vaccine (e.g., VGX‑3100): Clinical trials ongoing; aims to boost cellular immunity against HPV 6/11.

3. Airway support

• Tracheostomy is reserved for life‑threatening obstruction when endoscopic removal is insufficient.
• Continuous positive airway pressure (CPAP) may be used for obstructive sleep apnea caused by upper airway lesions.

4. Lifestyle and supportive measures

• Voice therapy with a speech‑language pathologist to reduce phonatory strain.
• Avoidance of tobacco smoke and other airway irritants.
• Vaccination of the child (if age‑appropriate) with the 9‑valent HPV vaccine may reduce recurrence, though data are still emerging.

Living with Juvenile Recurrent Respiratory Papillomatosis

Living with JRRP requires ongoing vigilance and collaboration with health‑care providers.

Daily management tips

• Hydration: Keep the airway moist; encourage water intake and use a humidifier, especially in dry climates.
• Voice conservation: Use a softer speaking voice, avoid shouting or whispering (which strains vocal cords).
• Air quality: Keep the home free from smoke, strong fragrances, and dust.
• Nutrition: Ensure a balanced diet; if feeding difficulty exists, work with a dietitian.
• Regular follow‑up: Schedule ENT appointments every 2–4 months or sooner if symptoms change.
• Emergency plan: Keep a written plan (including contact numbers) for rapid evaluation if breathing worsens.

Psychosocial support

Repeated surgeries and voice changes can affect a child’s self‑esteem and school performance. Consider:

• Counseling or support groups for the child and family.
• School accommodations (e.g., microphone, extra time for oral presentations).
• Engagement with a speech therapist to improve communication confidence.

Prevention

Because JRRP is linked to maternal HPV infection, primary prevention focuses on reducing HPV transmission.

Vaccination

• HPV vaccine (9‑valent, covering types 6/11): Recommended for females and males 11–12 years old; can be given as early as age 9. Immunizing girls before they become pregnant reduces the risk of transmitting HPV to their offspring.
• Pregnant women are not vaccinated, but catch‑up vaccination after delivery is advised.

Maternal screening & counseling

• Testing for genital HPV in women planning pregnancy can identify carriers.
• Discussion of delivery method: elective cesarean may reduce exposure to HPV, though evidence is mixed; decision should be individualized.

General infection control

• Hand hygiene for caregivers.
• Avoid sharing oral utensils or smoking around the child.

Complications

If left untreated or inadequately controlled, JRRP can lead to serious health problems.

• Airway obstruction: Progressive growth can cause acute or chronic respiratory distress, requiring emergent tracheostomy.
• Voice impairment: Persistent hoarseness may become permanent, affecting speech development.
• Recurrent infections: Stagnant secretions above papillomas predispose to bacterial pneumonia and otitis media.
• Malignant transformation: Rare (<1 %); long‑standing papillomas, especially those infected with HPV 11, have a small risk of developing squamous cell carcinoma in adulthood.
• Psychosocial impact: School absenteeism, anxiety, and depression due to chronic illness.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. “Human Papillomavirus (HPV) and Cancer.” 2023. https://www.cdc.gov/hpv/parents/about-hpv.html
2. Mayo Clinic. “Recurrent respiratory papillomatosis.” 2022. https://www.mayoclinic.org/diseases-conditions/recurrent-respiratory-papillomatosis/symptoms-causes/syc-20353540
3. American Academy of Otolaryngology–Head and Neck Surgery. “Guidelines for the Management of Juvenile Recurrent Respiratory Papillomatosis.” 2021. https://www.entnet.org/content/jrpp-guideline
4. World Health Organization. “Human papillomavirus (HPV) and cervical cancer.” 2023. https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer
5. Cleveland Clinic. “Recurrent Respiratory Papillomatosis (RRP).” 2022. https://my.clevelandclinic.org/health/diseases/17064-recurrent-respiratory-papillomatosis-rrp